NCT06891872View on ClinicalTrials.gov

Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP Vaccine

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

720

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Varicella (chickenpox)MMR VaccineDTaP Vaccine
Interventions
BIOLOGICAL

Vaicella Vaccine+DTaP on Day 0, MMR on Day 30

"Varicella vaccine: lyophilized powder, subcutaneous injection~DTaP: intramuscular injection~MMR: lyophilized powder, subcutaneous injection"

BIOLOGICAL

Varicella vaccine+MMR on Day 0，DTaP on Day 30

"Varicella vaccine: lyophilized powder, subcutaneous injection~MMR: lyophilized powder, subcutaneous injection~DTaP: intramuscular injection"

BIOLOGICAL

Varicella Vaccine

lyophilized powder, subcutaneous injection

Trial Locations (1)

400042

Chongqing Center for Disease Control and Prevention, Chongqing

All Listed Sponsors
lead

Sinovac (Dalian) Vaccine Technology Co., Ltd.

INDUSTRY